Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Bianchi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicinP A Trail, D Willner, A B Bianchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomasA B Bianchi, S I Mitsunaga, J Q Cheng, et al.
Nature Genetics|February 1, 1994
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour typesA B Bianchi, T Hara, V Ramesh, et al.
American Journal of Human Genetics|June 1, 1994
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomasR H Lekanne Deprez, A B Bianchi, N A Groen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicinP A Trail, D Willner, A B Bianchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomasA B Bianchi, S I Mitsunaga, J Q Cheng, et al.
Nature Genetics|February 1, 1994
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour typesA B Bianchi, T Hara, V Ramesh, et al.
American Journal of Human Genetics|June 1, 1994
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomasR H Lekanne Deprez, A B Bianchi, N A Groen, et al.
Pageof 2